BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 110 filers reported holding BIONTECH SE in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,551,318 | -57.3% | 60,303 | -57.6% | 0.05% | -58.6% |
| Q2 2023 | $15,358,763 | -12.1% | 142,303 | -6.6% | 0.11% | -8.3% |
| Q1 2023 | $17,471,904 | -23.7% | 152,383 | 0.0% | 0.12% | -21.4% |
| Q4 2022 | $22,889,902 | -21.3% | 152,383 | -29.3% | 0.15% | -24.9% |
| Q3 2022 | $29,098,000 | -18.0% | 215,416 | -9.5% | 0.20% | -29.8% |
| Q2 2022 | $35,501,000 | -14.0% | 238,134 | -1.7% | 0.29% | +3.9% |
| Q1 2022 | $41,259,000 | -33.0% | 242,134 | +0.5% | 0.28% | -28.5% |
| Q4 2021 | $61,566,000 | +99.2% | 240,902 | +112.8% | 0.39% | +87.1% |
| Q3 2021 | $30,900,000 | +32.6% | 113,197 | +8.7% | 0.21% | +31.2% |
| Q2 2021 | $23,305,000 | +239.2% | 104,097 | +18.6% | 0.16% | +180.7% |
| Q1 2021 | $6,870,000 | -4.0% | 87,761 | 0.0% | 0.06% | 0.0% |
| Q4 2020 | $7,153,000 | -70.3% | 87,761 | -74.7% | 0.06% | -74.8% |
| Q3 2020 | $24,059,000 | -12.1% | 347,537 | -15.3% | 0.23% | -21.8% |
| Q2 2020 | $27,386,000 | – | 410,313 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $22,333,808 | 17.21% |
| Quinn Opportunity Partners LLC | 262,071 | $39,368,306 | 4.82% |
| Temasek Holdings (Private) Ltd | 4,378,022 | $657,666,465 | 3.84% |
| PARUS FINANCE (UK) Ltd | 29,988 | $4,504,797 | 3.06% |
| Top Ace Asset Management Ltd | 20,000 | $3,004,400 | 2.21% |
| Artia Global Partners LP | 37,108 | $5,574,364 | 2.12% |
| Boston Common Asset Management, LLC | 269,803 | $40,530 | 1.94% |
| FLOSSBACH VON STORCH AG | 3,282,723 | $493,130,649 | 1.88% |
| Redwood Investments, LLC | 87,540 | $13,150,259 | 1.76% |
| Baader Bank Aktiengesellschaft | 238,800 | $35,881,130 | 1.74% |